Bridgeway Capital Management, LLC Concert Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $154,000 - $349,800	55,000 Added 59.01%	148,200 $624,000
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $150,150 - $216,700	-55,000 Reduced 37.11%	93,200 $314,000
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.15 $111,267 - $145,665	35,100 Added 31.03%	148,200 $485,000
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $426,387 - $592,644	113,100 New	113,100 $477,000
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $450,060 - $664,704	-57,700 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $149,500 - $327,250	-25,000 Reduced 30.23%	57,700 $510,000
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $356,304 - $575,328	-62,400 Reduced 43.0%	82,700 $763,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $476,720 - $662,560	-50,500 Reduced 25.82%	145,100 $1.74 Million
Q1 2019 May 15, 2019	SELL	$12.07 - $17.54 $249,849 - $363,078	-20,700 Reduced 9.57%	195,600 $2.36 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $863,378 - $1.11 Million	51,300 Added 31.09%	216,300 $3.64 Million
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $40,404 - $58,863	-2,100 Reduced 1.26%	165,000 $3.78 Million
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $1.75 Million - $3.63 Million	125,000 Added 296.91%	167,100 $4.32 Million
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $585,611 - $644,551	42,100	42,100 $621,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.